Doctor-Patient Relationship Empirical Featured Informed Consent Mental Health Patient Care Pharmaceuticals Professional Regulation Research Misconduct Scientific Evidence A Precautionary Approach to Touch in Psychedelic-Assisted Therapy Read more: A Precautionary Approach to Touch in Psychedelic-Assisted Therapy
Empirical Featured Human Subjects Research Leah Pierson Research Funding Resource Allocation Scientific Evidence Picking Research Projects That Matter Read more: Picking Research Projects That Matter
Empirical Matt Bauer Publications Scientific Evidence The Risk of Scientific Misinformation with Preprints and Science Twitter Read more: The Risk of Scientific Misinformation with Preprints and Science Twitter
Empirical Featured Human Subjects Research Leah Pierson Public Health Race Research Funding Scientific Evidence The NIH Has the Opportunity to Address Research Funding Disparities Read more: The NIH Has the Opportunity to Address Research Funding Disparities
Bioethics Disability Health Law Policy Workshop Informed Consent Mental Health Patient Care Personhood Philosophy Legal Capacity and Persons with Disabilities’ Struggle to Reclaim Control over Their Lives Read more: Legal Capacity and Persons with Disabilities’ Struggle to Reclaim Control over Their Lives
aging Bioethics End-of-Life Featured Geriatrics Health Law Policy Workshop James Toomey Mental Health Patient Care Personhood Philosophy Publications Scientific Evidence There’s More to Decision-Making Capacity than Cognitive Function Read more: There’s More to Decision-Making Capacity than Cognitive Function
Contributors FDA Health Law Policy Human Subjects Research Immunization Jacob Sherkow Nicholson Price Pharmaceuticals Public Health Rachel Sachs Scientific Evidence Vaccines Why Do Differences in Clinical Trial Design Make It Hard to Compare COVID-19 Vaccines? Read more: Why Do Differences in Clinical Trial Design Make It Hard to Compare COVID-19 Vaccines?
Addiction Announcements Chloe Reichel FDA Featured Health Law Policy Informed Consent Insurance Intellectual Property Mason Marks Mental Health Neuroscience Off-Label Use Opioid Crisis Petrie-Flom Center Pharmaceuticals Public Health Race Research Funding Scientific Evidence Q&A with Mason Marks on New Psychedelics Law and Regulation Initiative Read more: Q&A with Mason Marks on New Psychedelics Law and Regulation Initiative
COVID and the Law FDA Health Law Policy Human Subjects Research Patient Care Pharmaceuticals Public Health Scientific Evidence Vaccines “Stick to the Science”? FDA, Ethics, and Pandemics Read more: “Stick to the Science”? FDA, Ethics, and Pandemics
Contributors FDA Health Law Policy Jacob Sherkow Nicholson Price Pharmaceuticals Public Health Rachel Sachs Vaccines What’s the Difference Between Vaccine Approval (BLA) and Authorization (EUA)? Read more: What’s the Difference Between Vaccine Approval (BLA) and Authorization (EUA)?